Researchers at the Texas A&M University Naresh K. Vashisht College of Medicine have identified time-specific patterns of brain activity following ketamine treatment in older adults with treatment-resistant depression. The findings, published in Translational Psychiatry, could help researchers identify potential biological markers associated with ketamine’s antidepressant effects and better understand why patients respond differently to treatment.
Ketamine is increasingly used as a rapid-acting treatment for treatment-resistant depression, but its use in older adults has not been widely adopted due to concerns of safety and efficacy associated with aging pathology.
To address these questions, the Experimental Psychopharmacology of Mood and Anxiety Disorders Lab (EPMAD Lab) at Texas A&M, led by Dr. Sanjay Mathew, professor and head of Psychiatry, has been studying how the brain responds to ketamine in U.S. veterans over 55 years old.
Dr. Nicholas Murphy, research associate professor in the Department of Psychiatry and Behavioral Sciences at Texas A&M, coordinates the neuroscience-informed treatments wing of the EPMAD Lab. He compares ketamine’s effects to opening a floodgate: the drug allows communication to flow through the brain, leading to enhanced flexibility.
Murphy suggested patients’ clinical response to ketamine is tied more closely to the malleability of the brain than how large of an initial response it has.
“Let’s say you had a map of rivers in the desert,” he said. “You release the dam, and now all the tributaries are being flooded with water. We now have these connections between places, and that’s what ketamine does; it helps to create a more flexible and densely connected environment. But this isn’t the end of the story.
For it to be useful, we need to understand how that water is flowing, and that’s where our current analysis comes in. It tells us how the surging of glutamate released by ketamine needs to flow to get a clinical response.”


